Clinical trials of PUFAs in depression: State of the art
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis Ltd in The World Journal of Biological Psychiatry
- Vol. 7 (4), 223-230
- https://doi.org/10.1080/15622970600960173
Abstract
Omega fatty acid treatment of depression is an unusual story in psychopharmacology in that the use and study of these compounds were advanced in cardiovascular disease before becoming of interest in psychiatry. Given the absence of an easily patentable derivative it is a tribute to the field that enough studies have accumulated for a reasonable review of omega-3 treatment of depression at this time. On the other hand, it is clearly not possible to compare the number of studies, variety of studies and the number of participants in each study with Federal Drug Administration style registration trials of patented antidepressant drugs. Most of the available studies of omega-3 in depression have been investigator initiated and use add-on design. This paper reviews 12 published and as yet unpublished clinical trials (all but one double-blind placebo-controlled) of polyunsaturated fatty acids in unipolar depression, bipolar disorder, and special populations with affective/depressive disorders. While overall results up to this point are encouraging, they are not unanimously positive. Outstanding issues that have not as yet been resolved include the dose of omega-3 necessary and the length of time required for significant response. Moreover, the complex issue of the relationship between two possible active ingredients, eicosapentaenoic acid and docosahexaenoic acid, remains unresolved.Keywords
This publication has 33 references indexed in Scilit:
- Cognitive and physiological effects of Omega‐3 polyunsaturated fatty acid supplementation in healthy subjectsEuropean Journal of Clinical Investigation, 2005
- Randomized dose‐ranging pilot trial of omega‐3 fatty acids for postpartum depressionActa Psychiatrica Scandinavica, 2005
- Omega-3 Eicosapentaenoic Acid in Bipolar DepressionPublished by Physicians Postgraduate Press, Inc ,2005
- Omega-3 fatty acids for the prevention of postpartum depression: Negative data from a preliminary, open-label pilot studyDepression and Anxiety, 2004
- Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trialEuropean Neuropsychopharmacology, 2003
- Fish oil prevents the adrenal activation elicited by mental stress in healthy menDiabetes & Metabolism, 2003
- A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major DepressionAmerican Journal of Psychiatry, 2003
- Omega-3 Fatty Acid Treatment of Women With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Pilot StudyAmerican Journal of Psychiatry, 2003
- Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive DisorderAmerican Journal of Psychiatry, 2002
- Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylaseHuman Psychopharmacology: Clinical and Experimental, 2001